
LINK . SPRINGER . COM {
}
Title:
Biochemical and structural characterization of beta-carbonic anhydrase from the parasite Trichomonas vaginalis | Journal of Molecular Medicine
Description:
Trichomonas vaginalis is a unicellular parasite and responsible for one of the most common sexually transmittable infections worldwide, trichomoniasis. Carbonic anhydrases (CAs) are enzymes found in all lifeforms and are known to play a vital role in many biochemical processes in organisms including the maintenance of acidâbase homeostasis. To date, eight evolutionarily divergent but functionally convergent forms of CAs (Îą, β, Îł, δ, Îś, Ρ, θ, and Κ) have been discovered. The human genome contains only Îą-CAs, whereas many clinically significant pathogens express only β-CAs and/or Îł-CAs. The characterization of pathogenic β- and Îł-CAs provides important knowledge for targeting these biomolecules to develop novel anti-invectives against trichomoniasis. Here, we report the recombinant production and characterization of the second β-CA of T. vaginalis (TvaCA2). Light scattering analysis revealed that TvaCA2 is a dimeric protein, which was further supported with in silico modeling, suggesting similar structures between TvaCA2 and the first β-CA of T. vaginalis (TvaCA1). TvaCA2 exhibited moderate catalytic activity with the following kinetic parameters: kcat of 3.8âĂâ105 sâ1 and kcat/KM of 4.4âĂâ107 Mâ1 sâ1. Enzyme activity inhibition was studied with a set of clinically used sulfonamides and sulfonamide derivates. Twenty-seven out of the 39 compounds resulted in inhibition with a nanomolar range. These initial results encourage for future work entailing the design of more potent inhibitors against TvaCA2, which may provide new assets to fight trichomoniasis. ⢠Protozoan parasite Trichomonas vaginalis has two β-carbonic anhydrases (TvaCA1/2). ⢠TvaCA1/TvaCA2 represents promising targets for antitrichomonal drug development. ⢠TvaCA2 is a dimer of 20.3 kDa and possesses moderate catalytic activity. ⢠The most efficient inhibitor was clinical drug acetazolamide with KI of 222.9 nM. ⢠The 39 tested sulfonamides form the basis for the design of more potent inhibitors.
Website Age:
28 years and 1 months (reg. 1997-05-29).
Matching Content Categories {đ}
- Science
- Education
- Health & Fitness
Content Management System {đ}
What CMS is link.springer.com built with?
Custom-built
No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.
Traffic Estimate {đ}
What is the average monthly size of link.springer.com audience?
đ Phenomenal Traffic: 5M - 10M visitors per month
Based on our best estimate, this website will receive around 5,000,016 visitors per month in the current month.
check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush
How Does Link.springer.com Make Money? {đ¸}
The income method remains a mystery to us.
The purpose of some websites isn't monetary gain; they're meant to inform, educate, or foster collaboration. Everyone has unique reasons for building websites. This could be an example. Link.springer.com might be plotting its profit, but the way they're doing it isn't detectable yet.
Keywords {đ}
tvaca, inhibition, article, cas, protein, google, scholar, vaginalis, anhydrase, chem, inhibitors, supuran, trichomonas, active, similar, carbonic, sequence, compound, kda, structure, med, data, compounds, site, molecular, sulfonamides, drug, size, parkkila, enzymes, profiles, determined, betacarbonic, clinically, activity, enzyme, multiple, analysis, characterization, full, hytĂśnen, trichomoniasis, human, pathogens, drugs, chromatography, fig, image, shown, hca,
Topics {âď¸}
int/mediacentre/factsheets/fs110/en/ nl/cgi-bin/emboss/supermatcher multiple sequence alignmentâjabaws protozoan beta-carbonic anhydrase primary open-angle glaucoma amber99sb-ildn force field article download pdf protinoÂŽ nickel-nitrilotriacetic acid poissonâboltzmann electrostatics calculations light-scattering detector based multiple sequence alignment additional c-terminal aas related subjects probable key factor stop-flow kinetic studies uk/tools/msa/clustalo full access parasite trichomonas vaginalis md-equilibrated homology model amber force field adenylyl cyclase cac1 involving multiple rounds Îł-ca specific inhibitors human Îą-ca isozymes beta-carbonic anhydrase beta-carbonic anhydrase 1 trichomonas vaginalis increases trichomonas vaginalis homolog ni2+-nta affinity chromatography carbonic anhydrase can2 privacy choices/manage cookies trichomonas vaginalis resistant develop high-affinity inhibitors 3-bromo-4-amino-benzenesulfonamide leishmania donovani chagasi figure 1 shows require multiple rounds protozoan parasite responsible moderate/weak tvaca2 inhibition size exclusion chromatography size-exclusion chromatography standard protein samples beta-carbonic anhydrases homology modeling pathogen-specific cas clustal omega tool beta-class enzyme cryptococcus neoformans showed md-equilibrated crystal structure biomolecular drug targets
Questions {â}
- Inhibition of Plasmodium falciparum carbonic anhydrase with aromatic sulfonamides: towards antimalarials with a novel mechanism of action?
Schema {đşď¸}
WebPage:
mainEntity:
headline:Biochemical and structural characterization of beta-carbonic anhydrase from the parasite Trichomonas vaginalis
description:Trichomonas vaginalis is a unicellular parasite and responsible for one of the most common sexually transmittable infections worldwide, trichomoniasis. Carbonic anhydrases (CAs) are enzymes found in all lifeforms and are known to play a vital role in many biochemical processes in organisms including the maintenance of acidâbase homeostasis. To date, eight evolutionarily divergent but functionally convergent forms of CAs (Îą, β, Îł, δ, Îś, Ρ, θ, and Κ) have been discovered. The human genome contains only Îą-CAs, whereas many clinically significant pathogens express only β-CAs and/or Îł-CAs. The characterization of pathogenic β- and Îł-CAs provides important knowledge for targeting these biomolecules to develop novel anti-invectives against trichomoniasis. Here, we report the recombinant production and characterization of the second β-CA of T. vaginalis (TvaCA2). Light scattering analysis revealed that TvaCA2 is a dimeric protein, which was further supported with in silico modeling, suggesting similar structures between TvaCA2 and the first β-CA of T. vaginalis (TvaCA1). TvaCA2 exhibited moderate catalytic activity with the following kinetic parameters: kcat of 3.8âĂâ105 sâ1 and kcat/KM of 4.4âĂâ107 Mâ1 sâ1. Enzyme activity inhibition was studied with a set of clinically used sulfonamides and sulfonamide derivates. Twenty-seven out of the 39 compounds resulted in inhibition with a nanomolar range. These initial results encourage for future work entailing the design of more potent inhibitors against TvaCA2, which may provide new assets to fight trichomoniasis. ⢠Protozoan parasite Trichomonas vaginalis has two β-carbonic anhydrases (TvaCA1/2). ⢠TvaCA1/TvaCA2 represents promising targets for antitrichomonal drug development. ⢠TvaCA2 is a dimer of 20.3 kDa and possesses moderate catalytic activity. ⢠The most efficient inhibitor was clinical drug acetazolamide with KI of 222.9 nM. ⢠The 39 tested sulfonamides form the basis for the design of more potent inhibitors.
datePublished:2021-10-15T00:00:00Z
dateModified:2021-10-15T00:00:00Z
pageStart:115
pageEnd:124
license:http://creativecommons.org/licenses/by/4.0/
sameAs:https://doi.org/10.1007/s00109-021-02148-1
keywords:
Beta-carbonic anhydrase
Trichomonas vaginalis
Protozoan
Kinetics
Inhibition
Homology modeling
Molecular Medicine
Human Genetics
Internal Medicine
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-021-02148-1/MediaObjects/109_2021_2148_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-021-02148-1/MediaObjects/109_2021_2148_Fig2_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-021-02148-1/MediaObjects/109_2021_2148_Fig3_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-021-02148-1/MediaObjects/109_2021_2148_Fig4_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-021-02148-1/MediaObjects/109_2021_2148_Fig5_HTML.png
isPartOf:
name:Journal of Molecular Medicine
issn:
1432-1440
0946-2716
volumeNumber:100
type:
Periodical
PublicationVolume
publisher:
name:Springer Berlin Heidelberg
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Linda J. UrbaĹski
url:http://orcid.org/0000-0002-3584-5244
affiliation:
name:Tampere University
address:
name:Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Andrea Angeli
affiliation:
name:UniversitĂ Degli Studi Di Firenze
address:
name:Neurofarba Department, Sezione Di Chimica Farmaceutica E Nutraceutica, UniversitĂ Degli Studi Di Firenze, Sesto Fiorentino (Firenze), Italy
type:PostalAddress
type:Organization
type:Person
name:Vasyl V. Mykuliak
affiliation:
name:Tampere University
address:
name:Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
type:PostalAddress
type:Organization
type:Person
name:Latifeh Azizi
affiliation:
name:Tampere University
address:
name:Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
type:PostalAddress
type:Organization
type:Person
name:Marianne Kuuslahti
affiliation:
name:Tampere University
address:
name:Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
type:PostalAddress
type:Organization
type:Person
name:Vesa P. HytĂśnen
affiliation:
name:Tampere University
address:
name:Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
type:PostalAddress
type:Organization
name:Fimlab Ltd, Tampere University Hospital
address:
name:Fimlab Ltd, Tampere University Hospital, Tampere, Finland
type:PostalAddress
type:Organization
type:Person
name:Claudiu T. Supuran
affiliation:
name:UniversitĂ Degli Studi Di Firenze
address:
name:Neurofarba Department, Sezione Di Chimica Farmaceutica E Nutraceutica, UniversitĂ Degli Studi Di Firenze, Sesto Fiorentino (Firenze), Italy
type:PostalAddress
type:Organization
type:Person
name:Seppo Parkkila
affiliation:
name:Tampere University
address:
name:Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
type:PostalAddress
type:Organization
name:Fimlab Ltd, Tampere University Hospital
address:
name:Fimlab Ltd, Tampere University Hospital, Tampere, Finland
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:1
type:ScholarlyArticle
context:https://schema.org
ScholarlyArticle:
headline:Biochemical and structural characterization of beta-carbonic anhydrase from the parasite Trichomonas vaginalis
description:Trichomonas vaginalis is a unicellular parasite and responsible for one of the most common sexually transmittable infections worldwide, trichomoniasis. Carbonic anhydrases (CAs) are enzymes found in all lifeforms and are known to play a vital role in many biochemical processes in organisms including the maintenance of acidâbase homeostasis. To date, eight evolutionarily divergent but functionally convergent forms of CAs (Îą, β, Îł, δ, Îś, Ρ, θ, and Κ) have been discovered. The human genome contains only Îą-CAs, whereas many clinically significant pathogens express only β-CAs and/or Îł-CAs. The characterization of pathogenic β- and Îł-CAs provides important knowledge for targeting these biomolecules to develop novel anti-invectives against trichomoniasis. Here, we report the recombinant production and characterization of the second β-CA of T. vaginalis (TvaCA2). Light scattering analysis revealed that TvaCA2 is a dimeric protein, which was further supported with in silico modeling, suggesting similar structures between TvaCA2 and the first β-CA of T. vaginalis (TvaCA1). TvaCA2 exhibited moderate catalytic activity with the following kinetic parameters: kcat of 3.8âĂâ105 sâ1 and kcat/KM of 4.4âĂâ107 Mâ1 sâ1. Enzyme activity inhibition was studied with a set of clinically used sulfonamides and sulfonamide derivates. Twenty-seven out of the 39 compounds resulted in inhibition with a nanomolar range. These initial results encourage for future work entailing the design of more potent inhibitors against TvaCA2, which may provide new assets to fight trichomoniasis. ⢠Protozoan parasite Trichomonas vaginalis has two β-carbonic anhydrases (TvaCA1/2). ⢠TvaCA1/TvaCA2 represents promising targets for antitrichomonal drug development. ⢠TvaCA2 is a dimer of 20.3 kDa and possesses moderate catalytic activity. ⢠The most efficient inhibitor was clinical drug acetazolamide with KI of 222.9 nM. ⢠The 39 tested sulfonamides form the basis for the design of more potent inhibitors.
datePublished:2021-10-15T00:00:00Z
dateModified:2021-10-15T00:00:00Z
pageStart:115
pageEnd:124
license:http://creativecommons.org/licenses/by/4.0/
sameAs:https://doi.org/10.1007/s00109-021-02148-1
keywords:
Beta-carbonic anhydrase
Trichomonas vaginalis
Protozoan
Kinetics
Inhibition
Homology modeling
Molecular Medicine
Human Genetics
Internal Medicine
image:
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-021-02148-1/MediaObjects/109_2021_2148_Fig1_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-021-02148-1/MediaObjects/109_2021_2148_Fig2_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-021-02148-1/MediaObjects/109_2021_2148_Fig3_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-021-02148-1/MediaObjects/109_2021_2148_Fig4_HTML.png
https://media.springernature.com/lw1200/springer-static/image/art%3A10.1007%2Fs00109-021-02148-1/MediaObjects/109_2021_2148_Fig5_HTML.png
isPartOf:
name:Journal of Molecular Medicine
issn:
1432-1440
0946-2716
volumeNumber:100
type:
Periodical
PublicationVolume
publisher:
name:Springer Berlin Heidelberg
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
type:Organization
author:
name:Linda J. UrbaĹski
url:http://orcid.org/0000-0002-3584-5244
affiliation:
name:Tampere University
address:
name:Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
type:PostalAddress
type:Organization
email:[email protected]
type:Person
name:Andrea Angeli
affiliation:
name:UniversitĂ Degli Studi Di Firenze
address:
name:Neurofarba Department, Sezione Di Chimica Farmaceutica E Nutraceutica, UniversitĂ Degli Studi Di Firenze, Sesto Fiorentino (Firenze), Italy
type:PostalAddress
type:Organization
type:Person
name:Vasyl V. Mykuliak
affiliation:
name:Tampere University
address:
name:Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
type:PostalAddress
type:Organization
type:Person
name:Latifeh Azizi
affiliation:
name:Tampere University
address:
name:Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
type:PostalAddress
type:Organization
type:Person
name:Marianne Kuuslahti
affiliation:
name:Tampere University
address:
name:Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
type:PostalAddress
type:Organization
type:Person
name:Vesa P. HytĂśnen
affiliation:
name:Tampere University
address:
name:Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
type:PostalAddress
type:Organization
name:Fimlab Ltd, Tampere University Hospital
address:
name:Fimlab Ltd, Tampere University Hospital, Tampere, Finland
type:PostalAddress
type:Organization
type:Person
name:Claudiu T. Supuran
affiliation:
name:UniversitĂ Degli Studi Di Firenze
address:
name:Neurofarba Department, Sezione Di Chimica Farmaceutica E Nutraceutica, UniversitĂ Degli Studi Di Firenze, Sesto Fiorentino (Firenze), Italy
type:PostalAddress
type:Organization
type:Person
name:Seppo Parkkila
affiliation:
name:Tampere University
address:
name:Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
type:PostalAddress
type:Organization
name:Fimlab Ltd, Tampere University Hospital
address:
name:Fimlab Ltd, Tampere University Hospital, Tampere, Finland
type:PostalAddress
type:Organization
type:Person
isAccessibleForFree:1
["Periodical","PublicationVolume"]:
name:Journal of Molecular Medicine
issn:
1432-1440
0946-2716
volumeNumber:100
Organization:
name:Springer Berlin Heidelberg
logo:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
type:ImageObject
name:Tampere University
address:
name:Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
type:PostalAddress
name:UniversitĂ Degli Studi Di Firenze
address:
name:Neurofarba Department, Sezione Di Chimica Farmaceutica E Nutraceutica, UniversitĂ Degli Studi Di Firenze, Sesto Fiorentino (Firenze), Italy
type:PostalAddress
name:Tampere University
address:
name:Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
type:PostalAddress
name:Tampere University
address:
name:Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
type:PostalAddress
name:Tampere University
address:
name:Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
type:PostalAddress
name:Tampere University
address:
name:Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
type:PostalAddress
name:Fimlab Ltd, Tampere University Hospital
address:
name:Fimlab Ltd, Tampere University Hospital, Tampere, Finland
type:PostalAddress
name:UniversitĂ Degli Studi Di Firenze
address:
name:Neurofarba Department, Sezione Di Chimica Farmaceutica E Nutraceutica, UniversitĂ Degli Studi Di Firenze, Sesto Fiorentino (Firenze), Italy
type:PostalAddress
name:Tampere University
address:
name:Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
type:PostalAddress
name:Fimlab Ltd, Tampere University Hospital
address:
name:Fimlab Ltd, Tampere University Hospital, Tampere, Finland
type:PostalAddress
ImageObject:
url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
name:Linda J. UrbaĹski
url:http://orcid.org/0000-0002-3584-5244
affiliation:
name:Tampere University
address:
name:Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
type:PostalAddress
type:Organization
email:[email protected]
name:Andrea Angeli
affiliation:
name:UniversitĂ Degli Studi Di Firenze
address:
name:Neurofarba Department, Sezione Di Chimica Farmaceutica E Nutraceutica, UniversitĂ Degli Studi Di Firenze, Sesto Fiorentino (Firenze), Italy
type:PostalAddress
type:Organization
name:Vasyl V. Mykuliak
affiliation:
name:Tampere University
address:
name:Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
type:PostalAddress
type:Organization
name:Latifeh Azizi
affiliation:
name:Tampere University
address:
name:Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
type:PostalAddress
type:Organization
name:Marianne Kuuslahti
affiliation:
name:Tampere University
address:
name:Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
type:PostalAddress
type:Organization
name:Vesa P. HytĂśnen
affiliation:
name:Tampere University
address:
name:Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
type:PostalAddress
type:Organization
name:Fimlab Ltd, Tampere University Hospital
address:
name:Fimlab Ltd, Tampere University Hospital, Tampere, Finland
type:PostalAddress
type:Organization
name:Claudiu T. Supuran
affiliation:
name:UniversitĂ Degli Studi Di Firenze
address:
name:Neurofarba Department, Sezione Di Chimica Farmaceutica E Nutraceutica, UniversitĂ Degli Studi Di Firenze, Sesto Fiorentino (Firenze), Italy
type:PostalAddress
type:Organization
name:Seppo Parkkila
affiliation:
name:Tampere University
address:
name:Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
type:PostalAddress
type:Organization
name:Fimlab Ltd, Tampere University Hospital
address:
name:Fimlab Ltd, Tampere University Hospital, Tampere, Finland
type:PostalAddress
type:Organization
PostalAddress:
name:Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
name:Neurofarba Department, Sezione Di Chimica Farmaceutica E Nutraceutica, UniversitĂ Degli Studi Di Firenze, Sesto Fiorentino (Firenze), Italy
name:Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
name:Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
name:Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
name:Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
name:Fimlab Ltd, Tampere University Hospital, Tampere, Finland
name:Neurofarba Department, Sezione Di Chimica Farmaceutica E Nutraceutica, UniversitĂ Degli Studi Di Firenze, Sesto Fiorentino (Firenze), Italy
name:Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland
name:Fimlab Ltd, Tampere University Hospital, Tampere, Finland
External Links {đ}(104)
- Financial intake of https://www.springernature.com/gp/authors
- What's the total monthly financial gain of https://link.springernature.com/home/?
- How much revenue does https://order.springer.com/public/cart bring in?
- https://www.springernature.com/gp/open-research/about/the-fundamentals-of-open-access-and-open-research's total income per month
- Get to know https://www.editorialmanager.com/jmme's earnings
- How much revenue does https://orcid.org/0000-0002-3584-5244 generate?
- How much does https://beta.springernature.com/pre-submission?journalId=109 net monthly?
- What are the earnings of https://doi.org/10.1080%2F14756366.2019.1683007?
- Income figures for http://scholar.google.com/scholar_lookup?&title=In%20vitro%20inhibition%20of%20Mycobacterium%20tuberculosis%20beta-carbonic%20anhydrase%203%20with%20mono-%20and%20dithiocarbamates%20and%20evaluation%20of%20their%20toxicity%20using%20zebrafish%20developing%20embryos&journal=J%20Enzyme%20Inhib%20Med%20Chem&doi=10.1080%2F14756366.2019.1683007&volume=35&issue=1&pages=65-71&publication_year=2020&author=Aspatwar%2CA&author=Hammaren%2CM&author=Parikka%2CM&author=Parkkila%2CS&author=Carta%2CF&author=Bozdag%2CM&author=Vullo%2CD&author=Supuran%2CCT
- Check the income stats for https://doi.org/10.1038%2Fs41396-019-0426-8
- Learn about the earnings of http://scholar.google.com/scholar_lookup?&title=A%20new%20widespread%20subclass%20of%20carbonic%20anhydrase%20in%20marine%20phytoplankton&journal=ISME%20J&doi=10.1038%2Fs41396-019-0426-8&volume=13&issue=8&pages=2094-2106&publication_year=2019&author=Jensen%2CEL&author=Clement%2CR&author=Kosta%2CA&author=Maberly%2CSC&author=Gontero%2CB
- How much income does https://doi.org/10.1021%2Facs.jmedchem.0c00734 have?
- How much does http://scholar.google.com/scholar_lookup?&title=Optimization%20of%20acetazolamide-based%20scaffold%20as%20potent%20inhibitors%20of%20vancomycin-resistant%20enterococcus&journal=J%20Med%20Chem&doi=10.1021%2Facs.jmedchem.0c00734&volume=63&issue=17&pages=9540-9562&publication_year=2020&author=Kaur%2CJ&author=Cao%2CX&author=Abutaleb%2CNS&author=Elkashif%2CA&author=Graboski%2CAL&author=Krabill%2CAD&author=AbdelKhalek%2CAH&author=An%2CW&author=Bhardwaj%2CA&author=Seleem%2CMN&author=Flaherty%2CDP bring in each month?
- What's https://doi.org/10.1021%2Fjm400939k's gross income?
- What's the profit of http://scholar.google.com/scholar_lookup?&title=Cloning%2C%20characterization%2C%20and%20inhibition%20studies%20of%20a%20beta-carbonic%20anhydrase%20from%20Leishmania%20donovani%20chagasi%2C%20the%20protozoan%20parasite%20responsible%20for%20leishmaniasis&journal=J%20Med%20Chem&doi=10.1021%2Fjm400939k&volume=56&issue=18&pages=7372-7381&publication_year=2013&author=Syrjanen%2CL&author=Vermelho%2CAB&author=Rodrigues%20Ide%2CA&author=Corte-Real%2CS&author=Salonen%2CT&author=Pan%2CP&author=Vullo%2CD&author=Parkkila%2CS&author=Capasso%2CC&author=Supuran%2CCT?
- How much does https://doi.org/10.1016%2F0002-9394%2889%2990807-6 make?
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Intraocular%20pressure%20effects%20of%20carbonic%20anhydrase%20inhibitors%20in%20primary%20open-angle%20glaucoma&journal=Am%20J%20Ophthalmol&doi=10.1016%2F0002-9394%2889%2990807-6&volume=107&issue=1&pages=11-17&publication_year=1989&author=Lichter%2CPR&author=Musch%2CDC&author=Medzihradsky%2CF&author=Standardi%2CCL?
- How much does https://doi.org/10.2174%2F156802607780636726 pull in?
- What is the monthly revenue of http://scholar.google.com/scholar_lookup?&title=Carbonic%20anhydrase%20inhibitors%20as%20anticonvulsant%20agents&journal=Curr%20Top%20Med%20Chem&doi=10.2174%2F156802607780636726&volume=7&issue=9&pages=855-864&publication_year=2007&author=Thiry%2CA&author=Dogne%2CJM&author=Supuran%2CCT&author=Masereel%2CB?
- What are the total earnings of http://www.who.int/mediacentre/factsheets/fs110/en/(07.03.2018)?
- Revenue of https://doi.org/10.1086%2F511278
- How much income does http://scholar.google.com/scholar_lookup?&title=Infection%20with%20Trichomonas%20vaginalis%20increases%20the%20risk%20of%20HIV-1%20acquisition&journal=J%20Infect%20Dis&doi=10.1086%2F511278&volume=195&issue=5&pages=698-702&publication_year=2007&author=McClelland%2CRS&author=Sangare%2CL&author=Hassan%2CWM&author=Lavreys%2CL&author=Mandaliya%2CK&author=Kiarie%2CJ&author=Ndinya-Achola%2CJ&author=Jaoko%2CW&author=Baeten%2CJM have?
- How much revenue does https://doi.org/10.1073%2Fpnas.1321884111 generate?
- http://scholar.google.com/scholar_lookup?&title=Trichomonas%20vaginalis%20homolog%20of%20macrophage%20migration%20inhibitory%20factor%20induces%20prostate%20cell%20growth%2C%20invasiveness%2C%20and%20inflammatory%20responses&journal=Proc%20Natl%20Acad%20Sci%20USA&doi=10.1073%2Fpnas.1321884111&volume=111&issue=22&pages=8179-8184&publication_year=2014&author=Twu%2CO&author=Dessi%2CD&author=Vu%2CA&author=Mercer%2CF&author=Stevens%2CGC&author=Miguel%2CN&author=Rappelli%2CP&author=Cocco%2CAR&author=Clubb%2CRT&author=Fiori%2CPL&author=Johnson%2CPJ's total income per month
- Explore the financials of https://doi.org/10.1080%2F14756366.2020.1774572
- How much does http://scholar.google.com/scholar_lookup?&title=Biochemical%20and%20structural%20characterisation%20of%20a%20protozoan%20beta-carbonic%20anhydrase%20from%20Trichomonas%20vaginalis&journal=J%20Enzyme%20Inhib%20Med%20Chem&doi=10.1080%2F14756366.2020.1774572&volume=35&issue=1&pages=1292-1299&publication_year=2020&author=Urba%C5%84ski%2CLJ&author=Fiore%2CA&author=Azizi%2CL&author=Hyt%C3%B6nen%2CVP&author=Kuuslahti%2CM&author=Buonanno%2CM&author=Monti%2CSM&author=Angeli%2CA&author=Zolfaghari%20Emameh%2CR&author=Supuran%2CCT&author=Simone%2CG&author=Parkkila%2CS generate monthly?
- What is the earnings of https://doi.org/10.1080%2F14756366.2021.1897802?
- How much profit does http://scholar.google.com/scholar_lookup?&title=Activation%20of%20the%20%CE%B2-carbonic%20anhydrase%20from%20the%20protozoan%20pathogen%20Trichomonas%20vaginalis%20with%20amines%20and%20amino%20acids&journal=J%20Enzyme%20Inhib%20Med%20Chem&doi=10.1080%2F14756366.2021.1897802&volume=36&issue=1&pages=758-763&publication_year=2021&author=Angeli%2CA&author=Urba%C5%84ski%2CLJ&author=Hyt%C3%B6nen%2CVP&author=Parkkila%2CS&author=Supuran%2CCT make?
- What's the total monthly financial gain of https://doi.org/10.1080%2F14756366.2020.1863958?
- How much does http://scholar.google.com/scholar_lookup?&title=Inhibition%20of%20the%20%CE%B2-carbonic%20anhydrase%20from%20the%20protozoan%20pathogen%20Trichomonas%20vaginalis%20with%20sulphonamides&journal=J%20Enzyme%20Inhib%20Med%20Chem&doi=10.1080%2F14756366.2020.1863958&volume=36&issue=1&pages=329-334&publication_year=2021&author=Urba%C5%84ski%2CLJ&author=Angeli%2CA&author=Hyt%C3%B6nen%2CVP&author=Fiore%2CA&author=Simone%2CG&author=Parkkila%2CS&author=Supuran%2CCT gross monthly?
- http://www.uniprot.org/(01.03.2017)'s revenue stream
- What's https://www.ebi.ac.uk/Tools/msa/clustalo(09.04)'s gross income?
- Earnings of https://doi.org/10.1093%2Fbioinformatics%2Fbtr304
- What's the profit of http://scholar.google.com/scholar_lookup?&title=Java%20bioinformatics%20analysis%20web%20services%20for%20multiple%20sequence%20alignment%E2%80%94JABAWS%3AMSA&journal=Bioinformatics&doi=10.1093%2Fbioinformatics%2Fbtr304&volume=27&issue=14&pages=2001-2002&publication_year=2011&author=Troshin%2CPV&author=Procter%2CJB&author=Barton%2CGJ?
- How much profit is https://www.bioinformatics.nl/cgi-bin/emboss/supermatcher(09.04) making per month?
- What is the monthly revenue of https://doi.org/10.1093%2Fnar%2Fgky427?
- How much does http://scholar.google.com/scholar_lookup?&title=SWISS-MODEL%3A%20homology%20modelling%20of%20protein%20structures%20and%20complexes&journal=Nucleic%20Acids%20Res&doi=10.1093%2Fnar%2Fgky427&volume=46&issue=W1&pages=W296-W303&publication_year=2018&author=Waterhouse%2CA&author=Bertoni%2CM&author=Bienert%2CS&author=Studer%2CG&author=Tauriello%2CG&author=Gumienny%2CR&author=Heer%2CFT&author=Beer%2CTAP&author=Rempfer%2CC&author=Bordoli%2CL&author=Lepore%2CR&author=Schwede%2CT bring in each month?
- How much profit is https://doi.org/10.1016%2Fj.softx.2015.06.001 making per month?
- http://scholar.google.com/scholar_lookup?&title=GROMACS%3A%20High%20performance%20molecular%20simulations%20through%20multi-level%20parallelism%20from%20laptops%20to%20supercomputers&journal=SoftwareX&doi=10.1016%2Fj.softx.2015.06.001&volume=1%E2%80%932&pages=19-25&publication_year=2015&author=Abraham%2CMJ&author=Murtola%2CT&author=Schulz%2CR&author=P%C3%A1ll%2CS&author=Smith%2CJC&author=Hess%2CB&author=Lindahl%2CE's revenue stream
- How much income is https://doi.org/10.1021%2Facs.jcim.9b00407 earning monthly?
- Financial intake of http://scholar.google.com/scholar_lookup?&title=Upgrading%20and%20Validation%20of%20the%20AMBER%20force%20field%20for%20histidine%20and%20cysteine%20zinc%28II%29-binding%20residues%20in%20sites%20with%20four%20protein%20ligands&journal=J%20Chem%20Inf%20Model&doi=10.1021%2Facs.jcim.9b00407&volume=59&issue=9&pages=3803-3816&publication_year=2019&author=Macchiagodena%2CM&author=Pagliai%2CM&author=Andreini%2CC&author=Rosato%2CA&author=Procacci%2CP
- How much money does https://doi.org/10.1021%2Facsomega.0c01337 generate?
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=Upgraded%20AMBER%20force%20field%20for%20zinc-binding%20residues%20and%20ligands%20for%20predicting%20structural%20properties%20and%20binding%20affinities%20in%20zinc-proteins&journal=ACS%20Omega&doi=10.1021%2Facsomega.0c01337&volume=5&issue=25&pages=15301-15310&publication_year=2020&author=Macchiagodena%2CM&author=Pagliai%2CM&author=Andreini%2CC&author=Rosato%2CA&author=Procacci%2CP?
- See how much https://doi.org/10.1021%2Fj100308a038 makes per month
- Get to know http://scholar.google.com/scholar_lookup?&title=The%20missing%20term%20in%20effective%20pair%20potentials&journal=J%20Phys%20Chem&doi=10.1021%2Fj100308a038&volume=91&issue=24&pages=6269-6271&publication_year=1987&author=Berendsen%2CHJC&author=Grigera%2CJR&author=Straatsma%2CTP's earnings
- How much money does https://doi.org/10.1002%2F%28SICI%291096-987X%28199709%2918%3A12%3C1463%3A%3AAID-JCC4%3E3.0.CO%3B2-H generate?
- What's the monthly money flow for http://scholar.google.com/scholar_lookup?&title=LINCS%3A%20a%20linear%20constraint%20solver%20for%20molecular%20simulations&journal=J%20Comput%20Chem&doi=10.1002%2F%28SICI%291096-987X%28199709%2918%3A12%3C1463%3A%3AAID-JCC4%3E3.0.CO%3B2-H&volume=18&issue=12&pages=1463-1472&publication_year=1997&author=Hess%2CB&author=Bekker%2CH&author=Berendsen%2CHJC&author=Fraaije%2CJGEM?
- Check the income stats for https://doi.org/10.1063%2F1.470117
- What are the total earnings of http://scholar.google.com/scholar_lookup?&title=A%20smooth%20particle%20mesh%20Ewald%20method&journal=J%20Chem%20Phys&doi=10.1063%2F1.470117&volume=103&issue=19&pages=8577-8593&publication_year=1995&author=Essmann%2CU&author=Perera%2CL&author=Berkowitz%2CML&author=Darden%2CT&author=Lee%2CH&author=Pedersen%2CLG?
- Get to know https://doi.org/10.1016%2Fj.jmb.2008.11.037's earnings
- How much revenue does http://scholar.google.com/scholar_lookup?&title=Structure%20and%20inhibition%20of%20the%20CO2-sensing%20carbonic%20anhydrase%20Can2%20from%20the%20pathogenic%20fungus%20Cryptococcus%20neoformans&journal=J%20Mol%20Biol&doi=10.1016%2Fj.jmb.2008.11.037&volume=385&issue=4&pages=1207-1220&publication_year=2009&author=Schlicker%2CC&author=Hall%2CRA&author=Vullo%2CD&author=Middelhaufe%2CS&author=Gertz%2CM&author=Supuran%2CCT&author=Muhlschlegel%2CFA&author=Steegborn%2CC bring in?
- What's the revenue for https://doi.org/10.1074%2Fjbc.M800938200?
- Income figures for http://scholar.google.com/scholar_lookup?&title=Biochemical%20characterization%20of%20CA%20IX%2C%20one%20of%20the%20most%20active%20carbonic%20anhydrase%20isozymes&journal=J%20Biol%20Chem&doi=10.1074%2Fjbc.M800938200&volume=283&issue=41&pages=27799-27809&publication_year=2008&author=Hilvo%2CM&author=Baranauskiene%2CL&author=Salzano%2CAM&author=Scaloni%2CA&author=Matulis%2CD&author=Innocenti%2CA&author=Scozzafava%2CA&author=Monti%2CSM&author=Fiore%2CA&author=Simone%2CG&author=Lindfors%2CM&author=Janis%2CJ&author=Valjakka%2CJ&author=Pastorekova%2CS&author=Pastorek%2CJ&author=Kulomaa%2CMS&author=Nordlund%2CHR&author=Supuran%2CCT&author=Parkkila%2CS
- What's the revenue for https://doi.org/10.1038%2Fnrd2467?
- Profit of http://scholar.google.com/scholar_lookup?&title=Carbonic%20anhydrases%3A%20novel%20therapeutic%20applications%20for%20inhibitors%20and%20activators&journal=Nat%20Rev%20Drug%20Discov&doi=10.1038%2Fnrd2467&volume=7&issue=2&pages=168-181&publication_year=2008&author=Supuran%2CCT
- How much revenue does https://doi.org/10.1021%2Facsmedchemlett.7b00369 produce monthly?
- How much does http://scholar.google.com/scholar_lookup?&title=Benzoxaboroles%20as%20efficient%20inhibitors%20of%20the%20beta-carbonic%20anhydrases%20from%20Pathogenic%20fungi%3A%20activity%20and%20modeling%20study&journal=ACS%20Med%20Chem%20Lett&doi=10.1021%2Facsmedchemlett.7b00369&volume=8&issue=11&pages=1194-1198&publication_year=2017&author=Nocentini%2CA&author=Cadoni%2CR&author=Prete%2CS&author=Capasso%2CC&author=Dumy%2CP&author=Gratteri%2CP&author=Supuran%2CCT&author=Winum%2CJY earn?
- How much revenue does https://doi.org/10.1093%2Fnar%2Fgkg563 produce monthly?
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=ExPASy%3A%20the%20proteomics%20server%20for%20in-depth%20protein%20knowledge%20and%20analysis&journal=Nucleic%20Acids%20Res&doi=10.1093%2Fnar%2Fgkg563&volume=31&issue=13&pages=3784-3788&publication_year=2003&author=Gasteiger%2CE&author=Gattiker%2CA&author=Hoogland%2CC&author=Ivanyi%2CI&author=Appel%2CRD&author=Bairoch%2CA
- How much does https://doi.org/10.1021%2Fjm901855h pull in?
- Get to know what's the income of http://scholar.google.com/scholar_lookup?&title=Cloning%2C%20characterization%2C%20and%20inhibition%20studies%20of%20a%20beta-carbonic%20anhydrase%20from%20Brucella%20suis&journal=J%20Med%20Chem&doi=10.1021%2Fjm901855h&volume=53&issue=5&pages=2277-2285&publication_year=2010&author=Joseph%2CP&author=Turtaut%2CF&author=Ouahrani-Bettache%2CS&author=Montero%2CJL&author=Nishimori%2CI&author=Minakuchi%2CT&author=Vullo%2CD&author=Scozzafava%2CA&author=Kohler%2CS&author=Winum%2CJY&author=Supuran%2CCT
- How much revenue does https://doi.org/10.1016%2Fj.bmcl.2007.04.063 generate?
- What's the income of http://scholar.google.com/scholar_lookup?&title=Carbonic%20anhydrase%20inhibitors%3A%20the%20beta-carbonic%20anhydrase%20from%20Helicobacter%20pylori%20is%20a%20new%20target%20for%20sulfonamide%20and%20sulfamate%20inhibitors&journal=Bioorg%20Med%20Chem%20Lett&doi=10.1016%2Fj.bmcl.2007.04.063&volume=17&issue=13&pages=3585-3594&publication_year=2007&author=Nishimori%2CI&author=Minakuchi%2CT&author=Kohsaki%2CT&author=Onishi%2CS&author=Takeuchi%2CH&author=Vullo%2CD&author=Scozzafava%2CA&author=Supuran%2CCT?
- How much does https://doi.org/10.1016%2Fj.cub.2005.10.040 pull in?
- How much does http://scholar.google.com/scholar_lookup?&title=Fungal%20adenylyl%20cyclase%20integrates%20CO2%20sensing%20with%20cAMP%20signaling%20and%20virulence&journal=Current%20biology%20%3A%20CB&doi=10.1016%2Fj.cub.2005.10.040&volume=15&issue=22&pages=2021-2026&publication_year=2005&author=Klengel%2CT&author=Liang%2CWJ&author=Chaloupka%2CJ&author=Ruoff%2CC&author=Schr%C3%B6ppel%2CK&author=Naglik%2CJR&author=Eckert%2CSE&author=Mogensen%2CEG&author=Haynes%2CK&author=Tuite%2CMF&author=Levin%2CLR&author=Buck%2CJ&author=M%C3%BChlschlegel%2CFA pull in?
- How much does https://doi.org/10.1128%2FEC.5.1.103-111.2006 generate monthly?
- Find out how much http://scholar.google.com/scholar_lookup?&title=Cryptococcus%20neoformans%20senses%20CO2%20through%20the%20carbonic%20anhydrase%20Can2%20and%20the%20adenylyl%20cyclase%20Cac1&journal=Eukaryot%20Cell&doi=10.1128%2FEC.5.1.103-111.2006&volume=5&issue=1&pages=103-111&publication_year=2006&author=Mogensen%2CEG&author=Janbon%2CG&author=Chaloupka%2CJ&author=Steegborn%2CC&author=Fu%2CMS&author=Moyrand%2CF&author=Klengel%2CT&author=Pearson%2CDS&author=Geeves%2CMA&author=Buck%2CJ&author=Levin%2CLR&author=M%C3%BChlschlegel%2CFA earns monthly
- Learn about the earnings of https://citation-needed.springer.com/v2/references/10.1007/s00109-021-02148-1?format=refman&flavour=references
- How much money does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Linda%20J.%20Urba%C5%84ski generate?
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Linda%20J.%20Urba%C5%84ski%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en earn?
- How much does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Andrea%20Angeli rake in every month?
- How much revenue does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Andrea%20Angeli%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en generate?
- What's the profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Vasyl%20V.%20Mykuliak?
- What is the monthly revenue of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Vasyl%20V.%20Mykuliak%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- How much money does https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Latifeh%20Azizi make?
- https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Latifeh%20Azizi%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en's revenue stream
- How much profit is https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Marianne%20Kuuslahti making per month?
- What are the total earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Marianne%20Kuuslahti%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- Profit of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Vesa%20P.%20Hyt%C3%B6nen
- How much does https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Vesa%20P.%20Hyt%C3%B6nen%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en pull in?
- What's the financial outcome of https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Claudiu%20T.%20Supuran?
- What is the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Claudiu%20T.%20Supuran%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en?
- What's the revenue for https://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&term=Seppo%20Parkkila?
- Learn about the earnings of https://scholar.google.co.uk/scholar?as_q=&num=10&btnG=Search+Scholar&as_epq=&as_oq=&as_eq=&as_occt=any&as_sauthors=%22Seppo%20Parkkila%22&as_publication=&as_ylo=&as_yhi=&as_allsubj=all&hl=en
- What's the monthly income of https://static-content.springer.com/esm/art%3A10.1007%2Fs00109-021-02148-1/MediaObjects/109_2021_2148_MOESM1_ESM.docx?
- How much money does http://creativecommons.org/licenses/by/4.0/ make?
- How much cash flow does https://s100.copyright.com/AppDispatchServlet?title=Biochemical%20and%20structural%20characterization%20of%20beta-carbonic%20anhydrase%20from%20the%20parasite%20Trichomonas%20vaginalis&author=Linda%20J.%20Urba%C5%84ski%20et%20al&contentID=10.1007%2Fs00109-021-02148-1©right=The%20Author%28s%29&publication=0946-2716&publicationDate=2021-10-15&publisherName=SpringerNature&orderBeanReset=true&oa=CC%20BY have monthly?
- What are the total earnings of https://crossmark.crossref.org/dialog/?doi=10.1007/s00109-021-02148-1?
- Earnings of https://citation-needed.springer.com/v2/references/10.1007/s00109-021-02148-1?format=refman&flavour=citation
- Get to know what's the income of https://authorservices.springernature.com/go/sn/?utm_source=SNLinkfooter&utm_medium=Web&utm_campaign=SNReferral
- How much revenue does https://www.springernature.com/gp/products bring in?
- Find out how much https://www.springernature.com/gp/librarians earns monthly
- How much cash flow does https://www.springernature.com/gp/societies have monthly?
- What is the earnings of https://www.springernature.com/gp/partners?
- What's the financial intake of https://www.springer.com/?
- Get to know https://www.nature.com/'s earnings
- Financial intake of https://www.biomedcentral.com/
- How much does https://www.palgrave.com/ make?
- What's the financial outcome of https://www.apress.com/?
- https://www.springernature.com/gp/legal/ccpa's financial summary
- What's the financial outcome of https://www.springernature.com/gp/info/accessibility?
- What's the monthly income of https://support.springernature.com/en/support/home?
- How much cash flow does https://support.springernature.com/en/support/solutions/articles/6000255911-subscription-cancellations have monthly?
- How much revenue does https://www.springernature.com/ generate?
Analytics and Tracking {đ}
- Google Tag Manager
Libraries {đ}
- Clipboard.js
- Foundation
- Prism.js
CDN Services {đŚ}
- Crossref